▼«Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas asociadas a este medicamento.»
Roadshow

Special Guest: Prof. Philippe Moreau
Isatuximab clinical trial coordinator.
Nantes University Hospital Center. Nantes, France
-
17:00-17:10 H | Welcome & Introduction | Dr. Albert Oriol
17:10-17:30 H | Addressing the unmet need in Len refractory patients | Dr. Valentín Cabañas
17:30-17:45 H | All we want to know about IKEMA | Prof. Philippe Moreau
17:45-18:15 H | How we do it: SARCLISA®+Kd in real life | Dr. Antonia Sampol
18:15-18:25 H | Discussion | All
18:25-18:40 H | Coffe Break
18:40-18:55 H | All we want to know about ICARIA | Dr. Fernando Escalante
18:55-19:25 H | How we do it: SARCLISA +Pd in real life | Prof. Philippe Moreau
19:25-19:40 H | Making sense of the evolving treatment landscape: where does SARCLISA® fit? | Dr. Albert Oriol19:40-19:50 H | Discussion | All
19:50-20:10 H | A conversation with the MM experts. | All
20:10-20:20 H | Take away messages & Closing. | Dr. Albert Oriol
Scientific committe
Prof. Philippe Moreau
Nantes University Hospital Center. Nantes, FranceDr. Albert Oriol
Germans Trais i Pujol Hospital. Badalona, BarcelonaDr. Valentín Cabañas
Virgen de la Arrixaca University Hospital Clinic. MurciaDr. Antonia Sampol
Son Espases University Hospital, Palma de MallorcaDr. Fernando Escalante
León University Hospital. LeónDr. Carlos Fernandez Larrea
Hospital Clinic Barcelona -
17:00-17:10 H | Welcome & Introduction | Dr. María Victoria Mateos
17:10-17:30 H | Addressing the unmet need in Len refractory patients | Dr. Cristina Encinas
17:30-17:45 H | All we want to know about IKEMA | Prof. Philippe Moreau
17:45-18:15 H | How we do it: SARCLISA®+Kd in real life | Dr. María Casanova
18:15-18:25 H | Discussion | All
18:25-18:40 H | Coffe Break
18:40-18:55 H | All we want to know about ICARIA | Dr. Marta Sonia González
18:55-19:25 H | How we do it: SARCLISA +Pd in real life | Prof. Philippe Moreau
19:25-19:40 H | Making sense of the evolving treatment landscape: where does SARCLISA® fit? | Dr. Marivi Mateos19:40-19:50 H | Discussion | All
19:50-20:10 H | A conversation with the MM experts. | All
20:10-20:20 H | Take away messages & Closing. | Dr. María Victoria Mateos
Scientific committe
Prof. Philippe Moreau
Nantes University Hospital Center. Nantes, FranceDr. María Victoria Mateos
Salamanca University Hospital. SalamancaDr. Cristina Encinas
Gregorio Marañón University Hospital. MadridDr. María Casanova
Hospital Costa del Sol de MarbellaDr. Marta Sonia González
Santiago de Compostela University Hospital. La CoruñaDr. Joaquin Martinez
Hospital Universitario 12 de Octubre
MAT-ES-2300509 V1 Marzo 2023
REGISTER NOW TO THE LANDMARK EVENT IN MULTIPLE MYELOMA
Debate with HCP, generate synergies and develop news skills in the approach of patients with Myeloma.